February 12th 2020
By Andrew Smith
Personal health information isn’t truly private: Medical practices share records and companies sell internet search details. Here’s what patients should know.
February 7th 2020
By Beth Fand Incollingo
The novel drug pairing of Venclexta and Gazyva, used for a fixed 12 months, is cost-effective compared with regimens that must be taken until disease progresses, a study finds.
February 4th 2020
By Tamera Anderson-Hanna
There can be advantages to participating in a wellness program with your insurance company.
January 26th 2020
By Conor Killmurray
Racial and ethnic disparities have long been a part of the early detection of breast cancer in women, but a new study finds that these disparities are also connected by a patient’s insurance coverage.
October 29th 2019
By Kristie L. Kahl
Forty-eight percent of those surveyed by The Pink Fund said the cost of transportation was a barrier to receiving treatment and 60% missed an appointment or were late to one because of transportation issues.
October 5th 2019
By Tom Castles
How the high cost of cancer leaves many choosing between physical, financial and emotional health.
September 19th 2019
In this week’s episode of the “CURE Talks Cancer” podcast, we spoke with Dr. Benjamin Breyer about a phenomenon that’s raising big questions, big concerns and big money across the cancer landscape: crowdfunding.
September 12th 2019
By Katie Kosko
Here’s a sneak peek at what’s inside our Canadian issue.
September 11th 2019
By Mike Hennessy, Sr.
"We hope that this array of articles leaves you feeling informed about changes to your health-care system and some key supportive strategies that can improve your quality of life during treatment."
September 5th 2019
By Alan Birch
It can be challenging and confusing to get prescription drugs paid for in Canada. Drug access navigators can help.
Revolutionizing CAR T-Cell Therapy to Improve Patient Access
Understanding Financial Toxicity and Navigating the System During Cancer
What Is Immunotherapy-Induced Diabetes?
Breaking Down Every FDA Approval Across Oncology During July 2025